| GC47870-1mg |
|
902614-04-4 |
Pantothenate Kinase Inhibitor
|
0 |
C21H21N5OS |
|
|
|
| GC47869-25mg |
|
— |
Pancuronium (bromide hydrate)
|
0 |
C35H60N2O4.2Br [XH2O] |
|
|
|
| GC47869-10mg |
|
— |
Pancuronium (bromide hydrate)
|
0 |
C35H60N2O4.2Br [XH2O] |
|
|
|
| GC47869-5mg |
|
— |
Pancuronium (bromide hydrate)
|
0 |
C35H60N2O4.2Br [XH2O] |
|
|
|
| GC47868-5mg |
|
1334532-26-1 |
Palmitoyl-L-carnitine-d3 (chloride)
|
0 |
C23H43D3NO4.Cl |
|
|
|
| GC47868-1mg |
|
1334532-26-1 |
Palmitoyl-L-carnitine-d3 (chloride)
|
0 |
C23H43D3NO4.Cl |
|
|
|
| GC47868-500μg |
|
1334532-26-1 |
Palmitoyl-L-carnitine-d3 (chloride)
|
0 |
C23H43D3NO4.Cl |
|
|
|
| GC47867-25mg |
|
2932-74-3 |
Palmitoylcholine (chloride)
|
0 |
C21H44NO2.Cl |
|
|
|
| GC47867-10mg |
|
2932-74-3 |
Palmitoylcholine (chloride)
|
0 |
C21H44NO2.Cl |
|
|
|
| GC47867-5mg |
|
2932-74-3 |
Palmitoylcholine (chloride)
|
0 |
C21H44NO2.Cl |
|
|
|
| GC47866-5mg |
|
— |
Palmitoyl Ethanolamide-d5
|
0 |
C18H32D5NO2 |
|
|
|
| GC47866-1mg |
|
— |
Palmitoyl Ethanolamide-d5
|
0 |
C18H32D5NO2 |
|
|
|
| GC47866-500μg |
|
— |
Palmitoyl Ethanolamide-d5
|
0 |
C18H32D5NO2 |
|
|
|
| GC47866-100μg |
|
— |
Palmitoyl Ethanolamide-d5
|
0 |
C18H32D5NO2 |
|
|
|
| GC47865-5mg |
|
946524-34-1 |
Palmitoyl Ethanolamide-d4
|
0 |
C18H33D4NO2 |
|
|
|
| GC47865-1mg |
|
946524-34-1 |
Palmitoyl Ethanolamide-d4
|
0 |
C18H33D4NO2 |
|
|
|
| GC47865-500μg |
|
946524-34-1 |
Palmitoyl Ethanolamide-d4
|
0 |
C18H33D4NO2 |
|
|
|
| GC47865-100μg |
|
946524-34-1 |
Palmitoyl Ethanolamide-d4
|
0 |
C18H33D4NO2 |
|
|
|
| GC47864-5mg |
|
184708-66-5 |
|
0 |
C16H16D14O2 |
|
|
|
| GC47864-1mg |
|
184708-66-5 |
|
0 |
C16H16D14O2 |
|
|
|
